Kirsten Lindner, Jochen Kussmann, Volker Fendrich, K Alexander Iwen, Alexandra Zahn
{"title":"Adenoma weight: the only predictive factor for multiple gland disease in primary hyperparathyroidism.","authors":"Kirsten Lindner, Jochen Kussmann, Volker Fendrich, K Alexander Iwen, Alexandra Zahn","doi":"10.23736/S2724-6507.23.03883-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Predicting a multiple gland disease (MGD) in primary hyperparathyroidism (pHPT) remains challenging. This study aimed to evaluate predictive factors for MGD.</p><p><strong>Methods: </strong>A retrospective chart review was performed of 1211 patients with histologically confirmed parathyroid adenoma or hyperplasia between 2007-2016. Localization diagnostics, laboratory parameters, and the weight of the resected parathyroid glands were evaluated concerning their predictive value of a multiple-gland disease.</p><p><strong>Results: </strong>A number of 1111 (91.7%) had a single-gland disease (SGD), and 100 (8.3%) a multiple-gland disease (MGD). US and MIBI scans were comparable for either negative or positive adenoma localization and suspected MGD. While the PTH level was similar, the calcium level was higher in SGD (2.8 mmol/L versus 2.76 mmol/L, P=0.034). MGD had a significantly lower gland weight (0.78 g versus 0.31 g; P<0.001). A gland weight of 0.418 grams was a predictive factor for MGD with a sensitivity of 72% and a specificity of 66%.</p><p><strong>Conclusions: </strong>Only the weight of the resected parathyroid adenoma was meaningful in predicting MGD. A cut-off value of 0.418 g can differentiate SGD from MGD.</p>","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2023-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S2724-6507.23.03883-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Predicting a multiple gland disease (MGD) in primary hyperparathyroidism (pHPT) remains challenging. This study aimed to evaluate predictive factors for MGD.
Methods: A retrospective chart review was performed of 1211 patients with histologically confirmed parathyroid adenoma or hyperplasia between 2007-2016. Localization diagnostics, laboratory parameters, and the weight of the resected parathyroid glands were evaluated concerning their predictive value of a multiple-gland disease.
Results: A number of 1111 (91.7%) had a single-gland disease (SGD), and 100 (8.3%) a multiple-gland disease (MGD). US and MIBI scans were comparable for either negative or positive adenoma localization and suspected MGD. While the PTH level was similar, the calcium level was higher in SGD (2.8 mmol/L versus 2.76 mmol/L, P=0.034). MGD had a significantly lower gland weight (0.78 g versus 0.31 g; P<0.001). A gland weight of 0.418 grams was a predictive factor for MGD with a sensitivity of 72% and a specificity of 66%.
Conclusions: Only the weight of the resected parathyroid adenoma was meaningful in predicting MGD. A cut-off value of 0.418 g can differentiate SGD from MGD.
背景:预测原发性甲状旁腺功能亢进(pHPT)的多腺体疾病(MGD)仍然具有挑战性。本研究旨在评估MGD的预测因素。方法:回顾性分析2007-2016年1211例经组织学证实的甲状旁腺腺瘤或增生患者的资料。定位诊断、实验室参数和切除甲状旁腺的重量评估其对多腺体疾病的预测价值。结果:1111例(91.7%)患有单腺疾病(SGD), 100例(8.3%)患有多腺疾病(MGD)。US和MIBI扫描对于阴性或阳性腺瘤定位和疑似MGD具有可比性。虽然甲状旁腺素水平相似,但SGD的钙水平更高(2.8 mmol/L vs 2.76 mmol/L, P=0.034)。MGD组的腺体重量显著降低(0.78 g vs 0.31 g;结论:只有切除的甲状旁腺瘤的重量对预测MGD有意义。截断值0.418 g可以区分SGD和MGD。